Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147,048 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study.
Wang W, Xu C, Chen H, Jia J, Wang L, Feng H, Wang H, Song Z, Yang N, Zhang Y. Wang W, et al. Among authors: wang h, wang l. Lung Cancer. 2021 May;155:20-27. doi: 10.1016/j.lungcan.2021.03.006. Epub 2021 Mar 9. Lung Cancer. 2021. PMID: 33714778
Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center study.
Lei L, Wang WX, Zhu YC, Li JL, Fang Y, Wang H, Zhuang W, Zhang YB, Wang LP, Fang MY, Xu CW, Wang XJ, Lv TF, Song Y. Lei L, et al. Among authors: wang h, wang xj, wang wx, wang lp. Cancer Sci. 2020 Feb;111(2):679-686. doi: 10.1111/cas.14277. Epub 2020 Jan 16. Cancer Sci. 2020. PMID: 31828849 Free PMC article.
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study.
Wang W, Gu X, Wang L, Pu X, Feng H, Xu C, Lou G, Shao L, Xu Y, Wang Q, Wang S, Gao W, Zhang Y, Song Z. Wang W, et al. Among authors: wang l, wang s, wang q. Cancer Immunol Immunother. 2022 Jul;71(7):1693-1703. doi: 10.1007/s00262-021-03115-y. Epub 2021 Nov 24. Cancer Immunol Immunother. 2022. PMID: 34817639 Free PMC article.
Real-world efficacy and potential mechanism of resistance of icotinib in Asian advanced non-small cell lung cancer with EGFR uncommon mutations: A multi-center study.
Lei L, Wang WX, Zhu YC, Li JL, Fang Y, Wang H, Zhuang W, Zhang YB, Wang LP, Fang MY, Xu CW, Wang XJ, Lv TF, Song Y. Lei L, et al. Among authors: wang h, wang xj, wang wx, wang lp. Cancer Med. 2020 Jan;9(1):12-18. doi: 10.1002/cam4.2652. Epub 2019 Nov 6. Cancer Med. 2020. PMID: 31692291 Free PMC article.
A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations.
Lei L, Wang WX, Yu ZY, Liang XB, Pan WW, Chen HF, Wang LP, Fang Y, Wang M, Xu CW, Fang MY. Lei L, et al. Among authors: wang wx, wang lp, wang m. Transl Oncol. 2020 Feb;13(2):329-335. doi: 10.1016/j.tranon.2019.12.004. Epub 2019 Dec 24. Transl Oncol. 2020. PMID: 31881505 Free PMC article.
Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with EGFR exon 20 insertion mutation: a multicenter study.
Xu CW, Wang WX, Wang D, Wang QM, Pu XX, Zhu YC, Huang JH, Yu ZY, Cui ZL, Chen XH, Li JL, Fang Y, Wang H, Zhuang W, Lan SJ, Cai X, Zhang YB, Gao WB, Wang LP, She KL, Rao CZ, Zhou YF, Fang MY, Miao LY, Lei L, Lv TF, Song Y. Xu CW, et al. Among authors: wang qm, wang h, wang wx, wang lp, wang d. Transl Lung Cancer Res. 2020 Oct;9(5):1853-1861. doi: 10.21037/tlcr-20-382. Transl Lung Cancer Res. 2020. PMID: 33209607 Free PMC article.
Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective study.
Lei L, Wang WX, Zhu YC, Pu XX, Fang Y, Wang H, Zhuang W, Zhang YB, Wang LP, Xu CW, Fang MY. Lei L, et al. Among authors: wang h, wang wx, wang lp. Transl Cancer Res. 2020 Oct;9(10):6039-6049. doi: 10.21037/tcr-20-480. Transl Cancer Res. 2020. PMID: 35117215 Free PMC article.
147,048 results
You have reached the last available page of results. Please see the User Guide for more information.